Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials

作者
Jarem Edwards,Annie Tasker,Inês Pires da Silva,Camelia Quek,Marcel Batten,Angela L. Ferguson,Ruth Allen,Benjamin Allanson,Robyn P.M. Saw,John F. Thompson,Alexander M. Menzies,Umaimainthan Palendira,James S. Wilmott,Georgina V. Long,Richard A. Scolyer
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:25 (11): 3247-3258 被引量:37
标识
DOI:10.1158/1078-0432.ccr-18-4011
摘要

Abstract Purpose: Immunotherapies targeting costimulating and coinhibitory checkpoint receptors beyond PD-1 and CTLA-4 have entered clinical trials. Little is known about the relative abundance, coexpression, and immune cells enriched for each specific drug target, limiting understanding of the biological basis of potential treatment outcomes and development of predictive biomarkers for personalized immunotherapy. We sought to assess the abundance of checkpoint receptors during melanoma disease progression and identify immune cells enriched for them. Experimental Design: Multiplex immunofluorescence staining for immune checkpoint receptors (ICOS, GITR, OX40, PD-1, TIM-3, VISTA) was performed on 96 melanoma biopsies from 41 treatment-naïve patients, including patient-matched primary tumors, nodal metastases, and distant metastases. Mass cytometry was conducted on tumor dissociates from 18 treatment-naïve melanoma metastases to explore immune subsets enriched for checkpoint receptors. Results: A small subset of tumor-infiltrating leukocytes expressed checkpoint receptors at any stage of melanoma disease. GITR and OX40 were the least abundant checkpoint receptors, with <1% of intratumoral T cells expressing either marker. ICOS, PD-1, TIM-3, and VISTA were most abundant, with TIM-3 and VISTA mostly expressed on non-T cells, and TIM-3 enriched on dendritic cells. Tumor-resident T cells (CD69+/CD103+/CD8+) were enriched for TIGIT (>70%) and other coinhibitory but not costimulatory receptors. The proportion of GITR+ T cells decreased from primary melanoma (>5%) to lymph node (<1%, P = 0.04) and distant metastases (<1%, P = 0.0005). Conclusions: This study provides the first comprehensive assessment of immune checkpoint receptor expression in any cancer and provides important data for rational selection of targets for trials and predictive biomarker development.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Hello的应助被拼搏的白玉采纳,获得10
1秒前
Hupdou完成签到,获得积分10
1秒前
2秒前
虎虎发布了新的文献求助10
2秒前
6a完成签到 ,获得积分10
2秒前
2秒前
JamesPei的应助被whisper采纳,获得10
3秒前
我有颗糖发布了新的文献求助10
3秒前
大个的应助被喵喵采纳,获得10
3秒前
车紊发布了新的文献求助10
4秒前
杨凡华发布了新的文献求助10
4秒前
傻傻的起眸完成签到,获得积分10
4秒前
郭佳佳完成签到,获得积分10
5秒前
李李完成签到,获得积分10
5秒前
5秒前
5秒前
自成发布了新的文献求助10
5秒前
huagelihai完成签到,获得积分10
5秒前
5秒前
123发布了新的文献求助10
6秒前
6秒前
6秒前
8秒前
8秒前
可乐发布了新的文献求助10
8秒前
David完成签到,获得积分10
9秒前
9秒前
9秒前
爱笑绿柳完成签到,获得积分10
9秒前
cbs完成签到 ,获得积分10
10秒前
10秒前
能干的绯发布了新的文献求助10
10秒前
书包王发布了新的文献求助10
11秒前
杨凡华完成签到,获得积分10
11秒前
12秒前
科研通AI2S的应助被Shu舒采纳,获得10
12秒前
12秒前
领导范儿的应助被南海神尼采纳,获得10
12秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181155
求助须知:如何正确求助?哪些是违规求助? 9571140
关于积分的说明 21816740
捐赠科研通 7777528
什么是DOI,文献DOI怎么找? 3433436
关于科研通互助平台的介绍 2557664
邀请新用户注册赠送积分活动 2479482